BOME Therapeutics
PrivateCompany Overview
BOME Therapeutics operates in Healthcare & Life Sciences and is based in Millville, New Jersey.
BOME Therapeutics is a biotechnology company developing allergen immunotherapy vaccines based on its proprietary Antigen Delivery by Precipitation (ADBP) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOME Therapeutics Comparables
Compare BOME Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hapten Sciences, Inc. | 90% | |
| Angany | 76% | |
| Desentum Oy | 72% |
For institutional investors. Book with your work email.
BOME Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 55% MoM.
For institutional investors. Book with your work email.
BOME Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BOME Therapeutics's valuation, stock price, and market status.
Is BOME Therapeutics a public or private company?
BOME Therapeutics is a private company.
What is the current stock price of BOME Therapeutics?
BOME Therapeutics is a private company, so its shares have no public market price. Caplight tracks BOME Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BOME Therapeutics worth (valuation)?
Valuation information for BOME Therapeutics is not publicly available.
Can I buy BOME Therapeutics stock?
BOME Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BOME Therapeutics's last funding round?
Funding round information for BOME Therapeutics is not publicly available.
Who are the main investors in BOME Therapeutics?
Investor information for BOME Therapeutics is not publicly disclosed.
Will BOME Therapeutics IPO soon?
No public IPO plans have been announced for BOME Therapeutics.
How can I track BOME Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in BOME Therapeutics's shares on secondary markets.